Safety and tolerability of oxcarbazepine in elderly patients with epilepsy

Epilepsy and Behavior

Volumn 4, Issue 2, 2003, Pages 175-180

  Kutluay, Ekrem ^a   McCague, Kevin ^b   D'Souza, Joseph ^b   Beydoun, Ahmad ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Elderly; Epilepsy; Oxcarbazapine; Safety; Tolerability

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CLOBAZAM; DICLOFENAC; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETHOTOIN; LAXATIVE; MONOAMINE OXIDASE INHIBITOR; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; SODIUM; VALPROIC ACID; DRUG DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; ATAXIA; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIPLOPIA; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; EPILEPSY; EXPERIENCE; FATIGUE; FEMALE; GROUPS BY AGE; HUMAN; HYPONATREMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NAUSEA; POPULATION RESEARCH; SEIZURE; SODIUM BLOOD LEVEL; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VERTIGO; VIRUS INFECTION; VISUAL DISORDER; VOMITING; ADOLESCENT; DRUG TOLERANCE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CARBAMAZEPINE; DRUG TOLERANCE; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; SODIUM;

EID: 0037968501     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-5050(03)00037-4     Document Type: Article

References (18)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
2. Lühdorf K, Jensen LK, Plesner AM. Etiology of seizures in the elderly. Epilepsia 1986;27:458-63.
3. Ramsay RE, Pryor F. Epilepsy in the elderly. Neurology 2000;55(Suppl 1):9-14.
4. Lloyd P, Flesch G, Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 1994;35(Suppl 3):10-3.
5. 14C-oxcarbazepine in man. Xenobiotica 1986;16:769-78.
6. Baruzzi A, Albani F, Riva R. Oxcarbazepine: pharmacokinetic interactions and their clinical relevance. Epilepsia 1994;35(Suppl 3):14-9.
7. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in the elderly. Arch Fam Med 1994;3:589-98.
8. Dawling S, Crome P. Clinical pharmacokinetic considerations in the elderly: an update. Clin Pharmacokinet 1989;17:236-63.
9. Perucca E. The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 1999;40(Suppl 9):7-13.
10. Patterson M, Heazelwood R, Smithhurst B, et al. Plasma protein binding of phenytoin in the aged: in vivo studies. Br J Clin Pharmacol 1982;13:423-5.
11. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender and comedication on patterns of use. Epilepsia 1998;39:1083-7.
12. Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2001;3:59-71.
13. Heiningen PNM, Eve MD, Oosterhuis B, et al. The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine. Clin Pharmacol Ther 1991;50:410-9.
14. Rowe JW, Andres R, Tobin JD, et al. The effect of age on creatinine clearance in man: a cross sectional and longitudinal study. J Gerontol 1976;31:155-63.
15. Nielsen OA, Johannessen AC, Eardrum B. Oxcarbazepine-induced hyponatremia, a cross-sectional study. Epilepsy Res 1988;2:269-71.
16. Pendlebury SC, Moses DK, Eadie MJ. Hyponatremia during oxcarbazepine therapy. Hum Toxicol 1989;8:337-44.
17. Sachdeo R, Wasserstein A, Mesenbrink PJ, D'Souza J. Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol 2002;51:613-20.
18. Reeves WB, Bichet DG, Andreoli TE. Posterior pituitary and water metabolism. In: Williams HR, Foster DW, Kronenberg HM, Wilson, JD, editors. Williams textbook of endocrinology. Philadelphia: Saunders. p. 341-78.